Prostate Single Port & Laser Enucleation Comparison Trial

Part of paid clinical trials in Chicago, Illinois.

Sponsor
University of Illinois at Chicago
Study ID
NCT06224218
Status
Recruiting
Apply to this trial

Conditions

  • Prostate Hyperplasia

Eligibility Criteria

Sex
MALE
Age
18 Years - 88 Years
Healthy Volunteers
Not accepted

Interventions

  • Single Port Robotic Surgery — PROCEDURE
    Single port Robotic surgery will remove the whole prostate
  • Laser Surgery — PROCEDURE
    Laser enucleation will remove chips of the prostate but keeping intact the prostate capsule.

Study Details

Surgical treatments for benign prostatic hyperplasia (BPH) are necessary when non-procedural approaches fail to alleviate lower urinary tract symptoms (LUTS) or bladder outlet obstruction (BOO). Open simple prostatectomy and laser enucleation are recommended for prostatic adenoma size greater than 80 ml. Minimally invasive approaches, such as robotic-assisted simple prostatectomy, have gained popularity due to their comparable outcomes with lower morbidity. The introduction of the da Vinci single-port (SP) robotic platform offers potential advantages, but its outcomes have not been thoroughly investigated. This randomized controlled trial aims to compare the outcomes of SP simple prostatectomy performed using the da Vinci robotic platform versus thulium laser enucleation of the prostate for the treatment of BPH and BOO.

Key Dates

Start date
Jan 15, 2024
Status verified
May 2024
Primary completion
Jan 15, 2027
Completion
Aug 15, 2027

Study Design

Enrollment
116 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Single Port Robotic Prostatectomy
    Removal of the prostate using single port robot
  • Active Comparator: Laser Enucleation of the Prostate
    Enucleation of the prostate with laser surgery

Primary Outcome Measure

Operative time [ Time Frame: During procedure ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UI Health SCB Clinic Department of UrologyChicagoIllinois60612
Ruben Sauer, MD
[email protected]
312-413-5288
Simone Crivellaro, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Chicago, IL

By research site
UI Health SCB Clinic Department of Urology· Chicago, IL

Related Studies